Life Sciences Post-Chevron: Navigating the Range of Legal and Regulatory...
The US Supreme Court’s decision in Loper Bright Enterprises v. Raimondo and Relentless v. Department of Commerce, which overrules the longstanding Chevron doctrine that required federal courts to defer...
View ArticleFDA Issues Guidance on Foods Made from Genome-Edited Plants in Newest Update...
The US Food and Drug Administration (FDA) issued final guidance titled Foods Derived from Plants Produced Using Genome Editing (Genome-Edited Plants Guidance), describing the agency’s approach for...
View ArticleThe Horse Is Out of the Barn: FDA and AAFCO Memo of Understanding on Animal...
The Association of American Feed Control Officials (AAFCO) and the US Food and Drug Administration (FDA) announced on August 2, 2024 that their long-standing Memorandum of Understanding (MOU) governing...
View ArticleFood Safety 3.0: FDA Implements Human Foods Program Alongside Long-Awaited...
On October 1, 2024, the US Food and Drug Administration (FDA) announced the implementation of its long-promised reorganization, with the establishment of the unified Human Foods Program (HFP). The HFP...
View ArticleHow the US Election May Affect the FDA Regulation of Life Sciences Products –...
The reelection of former President Donald Trump, coupled with Republicans gaining the Senate majority and poised to gain the House majority, has prompted many in the life sciences industry to question...
View ArticleFDA Cosmetic Updates: New Q&As for MoCRA Facility Registration, Product...
FDA continues to construct its regulatory program for cosmetic products, albeit at a slower pace than the congressional timelines provided in the Modernization of Cosmetics Regulation Act of 2022...
View Article